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Dear Editor,
In a recent article published in the European Journal of Vascular
andEndovascular Surgery,Hellentahlet al. provided furtherevidence
that plasma biomarkers, such as matrix metalloproteinase-9 (MMP-
9), may be a valuable adjunctive diagnostic tool for predicting the
presence of an endoleak post endovascular aneurysmrepair (EVAR).1
Although EVAR compares favourably to open surgical abdom-
inal aortic aneurysm (AAA) repair in terms of short term mortality
and morbidity, the potential longer term complications mandate
the lifelong follow up post procedure. The cost involved with the
surveillance program, and the inconvenience for the patients to
partake in a lifelong surveillance, remain a signiﬁcant issue.2 There-
fore, the discovery of potential diagnostic plasma biomarker(s) for
the purpose of endoleak detectionwould represent a breakthrough
in current standard clinical practice; it would also underpin the
ethos of surgical translational research.
In our search for potential plasma biomarkers for clinical appli-
cations, it is critical to examine the pre-analytical factors which
may affect quantitative measurements of the biomarkers. MMP-9
is known to be affected by several pre-analytical issues, including
the kind of sample matrix collected or the type of anti-coagulants
used for the preparation of plasma. Blood components such aswhite
blood cells and platelets are sources of MMP-9 and may release
MMP-9 ex-vivo during the coagulation process. It has been shown
that serum levels ofMMP-9 are higher than thatmeasured in paired
plasma, and that higher levels of MMP-9 are measured in EDTA
plasma compared to paired lithium heparin plasma.3,4
Given the pre-analytical inﬂuence on themeasuredMMP-9 levels,
itwouldbeworthwhile for researchpublications, suchas the reportby
Hellentahl et al., to include the sample preparation protocol as part of
themethods section. Thiswill allow for comparisons between studies,
and to guide potential clinical applications in the future.Acknowledgement
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Re: Utility of Plasma Matrix Metalloproteinase-9 as a Possible
Diagnostic Marker of Endoleak Post Endovascular Aneurysm
Repair
Dear Sir,
We would like to thank Lee and Handa for their interest in and
commentary on our report. We share their views on the inﬂuence
of pre-analytical processing on the measured MMP-9 levels. More-
over, we support the necessity of inclusion of the sample prepara-
tion protocol for comparisons between studies. However, since the
nature of this article was a short report, we were unable to report
details of the materials and methods. We therefore gladly provide
the details on the pre-analytical processing of our samples and
assay protocol in the present reply.
Blood Collection
Venous blood was drawn via an antecubital vein puncture and
collected inEDTAbuffered (K2E7.2mg) vacutainer for plasma. ExactlyDOI of original article: 10.1016/j.ejvs.2012.01.033.
